Michael Meluzio's most recent trade in Cue Biopharma Inc was a trade of 40,942 Common Stock done . Disclosure was reported to the exchange on July 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Michael Meluzio | VP, Prin. Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 40,942 | 40,942 (0%) | 0% | 0 | Common Stock | |
| Cue Biopharma Inc | Michael Meluzio | VP, Prin. Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2026 | 40,942 | 40,942 | - | - | Common Stock |